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Abstract
Association of juvenile spondyloarthritis (jSpA) with the HLA-B27 genotype is well
established, but there is little knowledge of other genetic factors with a role in the
development of the disease. To date, only a few studies have tried to find those
associated genes by obtaining expression profiles, but with inconsistent results due
to various patient selection criteria and methodology. The aim of the present study
was to identify and confirm gene signatures and novel biomarkers in highly
homogeneous cohorts of untreated and treated patients diagnosed with jSpA and
other forms of juvenile idiopathic arthritis (JIA) according to ILAR criteria. For the
purposes of the research, total RNA was isolated from whole blood of 45 children
with jSpA and known HLA genotype, 11 children with oligo- and polyarticular forms
of JIA, as well as 12 age and sex matched control participants without diagnosis of
inflammatory disease. DNA microarray gene expression was performed in 11
patients with jSpA and in four healthy controls, along with bioinformatical analysis of
retrieved data. Carefully selected differentially expressed genes where analyzed by
qRT-PCR in all participants of the study. Microarray results and bioinformatical
analysis revealed 745 differentially expressed genes involved in various
inflammatory processes, while qRT-PCR analysis of selected genes confirmed data
universality and specificity of expression profiles in jSpA patients. The present
study indicates that jSpA could be a polygenic disease with a possible malfunction
in antigen recognition and activation of immunological response, migration of
inflammatory cells and regulation of the immune system. Among genes involved in
these processes TLR4, NLRP3, CXCR4 and PTPN12 showed almost consistent
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expression in study patients diagnosed with jSpA. Those genes and their products
could therefore potentially be used as novel biomarkers, possibly predictive of
disease prognosis and response to therapy, or even as a target for new therapeutic
approaches.
Introduction
Spondyloarthritis (SpA) is a term that comprises a group of seronegative,
immune-mediated inflammatory disorders with similar clinical and genetic
manifestations [1]. These diseases are characterized by enthesitis and arthritis
affecting the joints of the lower extremities and seronegativity for IgM rheumatoid
factor and antinuclear antibodies. The SpA family of diseases includes ankylosing
spondylitis (AS), reactive arthritis (ReA), psoriatic arthritis (PsA), arthritis
associated with inflammatory bowel disease (IBD), undifferentiated SpA and a
juvenile form of SpA (jSpA). The latter, according to ILAR (The International
League of Associations for Rheumatology) classification of juvenile idiopathic
arthritis (JIA), are classified as enthesitis-related arthritis (ErA), psoriatic arthritis
(PsA) or undifferentiated arthritis [2]. Nevertheless, the majority of jSpA patients
can be classified as ErA, which often leads to interchangeable use of terms. SpA
often begins as ‘‘undifferentiated’’ with different manifestation in children and
adults; most notably, spinal involvement is uncommon, while hip arthritis is
frequently seen in the juvenile-onset disease [3]. As a consequence, jSpA might be
missed or confused with other forms of juvenile arthritis.
SpA is a multifactorial disease in which a disturbed interplay occurs between
the immune system and environmental factors on a predisposing genetic
background, which is dominated by one family of MHC class I alleles, HLA-B27.
This genotype accounts for close to 40% of heritability in AS and seems almost
necessary for the disease development (present in more than 90% of AS patient
compared with 7–8% healthy controls), but is clearly not sufficient, since only 5%
of HLA-B27 carriers develop AS [4]. A similar role has also been proposed for
HLA-B7 [5, 6]. In our previous cohort study of 74 children from Croatia
diagnosed with jSpA/ErA, odds ratio (OR) for disease development were
calculated according to presence of HLA-B27 allele, HLA-B7 allele, or both [7]. It
has been shown that children with HLA-B7 allele have 2.61 times higher odds for
disease development than children from general Croatian population without this
allele. The odds were 5.69 times higher for children with HLA-B27 allele, and even
14.82 times higher if child had both HLA-B7 and HLA-B27 alleles.
Majority of studies today use the high-throughput methods that allow us to
study genes on a global scale. Recently, one of these methods was used to perform
a case-control association study in adult patients with AS [8]. The results
confirmed some genes previously identified in patients with SpA, such are ERAP1,
IL23R, IL12B, STAT3, PTGER4 and CARD9 [9]. These studies assessed the
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association between a common single nucleotide polymorphism (SNP) and a
complex disease. However, to understand the disease mechanism and close the
gap between genotype and phenotype, other genomic data, such as quantification
of gene expression, is often necessary. Gene expression profiling generates a
‘‘snapshot’’ of cellular activity at the time of analysis, telling us exactly what
processes are occurring. By comparing disease and control samples it is possible to
elucidate the processes contributing to the disease and how they are altered [10].
There are several methods of gene expression profiling, among which DNA
microarray is still the most common, accounting for almost 75.000 PubMed
results. This very sensitive method is influenced by a plethora of factors such are
patient selection, RNA isolation, chip selection, statistical and bioinformatical
analysis as well as independent data validation. To date, a number of various
expression profiling studies in patients diagnosed with SpA have been conducted,
which were mainly focused on AS patients [11–17]. There have also been some
studies involving patients with jSpA/ErA [18–21]. The results of these studies were
often inconsistent, which could be due to patient heterogeneity, different methods
of RNA isolation and expression analysis, variations in normalization procedures,
poorly preformed bioinformatical analysis and, most of all, a lack of independent
data validation. To the best of our knowledge, there has been no expression
profiling study with RNA isolated from whole blood in a cohort of patients
diagnosed with jSpA using ILAR criteria for ErA, with known HLA genotype and
calculated odds ratio for disease development. Furthermore, there has not been a
study in which an expression of selected genes was independently confirmed in
new cohorts of untreated and treated patients diagnosed with jSpA/ErA, as well as
with other forms of JIA. To summarize, the aim of the present study was to
identify and confirm gene signatures and novel biomarkers possibly predictive of
therapeutic response in various cohorts of untreated and treated patients
diagnosed with undifferentiated jSpA and other forms of JIA.
Materials and Methods
Patients
Peripheral blood samples were obtained at the Pediatric Rheumatology Clinic in
Children’s Hospital Srebrnjak from 45 patients with an undifferentiated form of
jSpA who fulfilled ILAR criteria for ErA and 11 patients who fulfilled ILAR criteria
for oligo- or polyarticular form of JIA [22]. Basic immunological tests (ANA, RF)
and HLA genotyping were performed in all the patients diagnosed with jSpA/ErA,
as well as spinal MRI in order to exclude the development of axial disease. Twelve
gender and age specific blood samples were collected from children with no
history of chronic diseases during their visit to the Pediatric Pulmology Clinics at
Children’s Hospital Srebrnjak.
All the participants were divided in several study groups. In the first group of
patients (P1) there were 11 children and in the second (P2) there were 10 children
diagnosed with jSpA/ErA whose blood samples were collected 12 to 24 weeks after
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the development of the first symptoms. These children were treated only with
non-steroidal anti-inflammatory drugs (NSAID), with a break in therapy at least
24 hours prior to blood sample collection. In the third patient group (P3) there
were 24 children diagnosed with jSpA/ErA whose blood was collected 24 or more
weeks after the development of the first symptoms. These patients were treated
with standard therapy for jSpA/ErA (NSAID, glucocorticoids, methotrexate). In
the fourth group (P4) there was 11 children diagnosed with oligo- or polyarticular
form of JIA who were also treated with standard therapy (NSAID, glucocorticoids,
methotrexate). None of the patients included in the study received a biological
therapy. Participants without a history of chronic disease were divided in two
groups depending on the obtained expression profile. In the first group there were
four participants (C1) and in the second group there were 12 participants (C2).
DNA microarray was performed in the 11 patients diagnosed with jSpA/ErA from
P1 group and in the four patients from C1 group. A qRT-PCR confirmation of
selected genes was performed in all the participants. Demographic characteristics,
diagnosis, performed analysis and HLA genotypes of all the participants are shown
in Table 1.
Ethics Statement
The study protocol was in compliance with the Helsinki Declaration and was
approved by the University of Zagreb School of Medicine and Children’s Hospital
Srebrnjak Institutional Review Board (IRB). Parents of all the participants as well
as the children older than 12 years have signed an informed consent prior to blood
collection.
RNA isolation
From each study participant 7.5 mL of venous blood was collected using three
PAXgene tubes for the stabilization of whole blood RNA (362.5 mL57.5 mL).
Total RNA was isolated from the whole blood using a RNA isolation kit
(PaxGene, Preanalytix) at the Department for Functional Genomics, Center for
Translational and Clinical Research of the University of Zagreb School of
Medicine. All the samples were treated with DNase (RNase-free DNase set,
Qiagen, Valencia, CA). The quality of the total RNA was analyzed using RNA 6000
Nano LabChip kit on 2100 Bioanalyser (Agilent Technologies, Santa Clara, CA).
Gene expression analysis
Microarray analysis was performed using an Affymetrix Human Genome U133
PLUS 2.0 GeneChip (Affymetrix, Santa Clara, CA) according to the manufac-
turer’s protocol. Briefly, 4 mg of high-quality total RNA was reverse-transcribed
(Invitrogen, Carlsbad, CA), cleaned with QIAquick purification kit (Qiagen,
Valencia, CA), and then used as a template for in vitro transcription with T7
MEGA script reagents (Ambion, Austin, TX). The resulting biotin-labeled cRNA
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was recovered and purified with the RNeasy kit (Qiagen, Valencia, CA),
hybridized to the chips, washed, stained on an Affymetrix fluidics station and
scanned using an Affymetrix GeneChip scanner. All arrays were run at the
Department for Functional Genomics, Center for Translational and Clinical
Research of the University of Zagreb School of Medicine.
Data processing and statistical analysis
After hybridization and scanning of microarray chips, raw signal intensities were
obtained from every probe. These raw intensities were subsequently corrected for
experimental noise in the signal through the process of normalization. We used
MAS5 and GeneChip Robust Multiarray Analysis (GCRMA) normalization
procedures and the resulting normalized probe intensities were used to compare
differential levels of gene expression between the patient and control samples.
Prior to normalization step with GCRMA algorithm, unspecific probes present in
Affymetrix microarrays that hybridize to many different mRNA transcripts were
removed, and henceforth not considered as a valid detector of the presence of
certain mRNA transcript [23]. All the microarray probe intensities processed in
Table 1. Demographic characteristics, diagnosis, performed analysis, therapy and HLA genotype of all study participants.
P1 P2 P3 P4 C1 C2
Demographics
N (m/f) 11 (6/5) 10 (4/6) 24 (11/13) 11 (3/8) 4 (1/3) 12 (6/6)
Age (mean years ¡SD) 12.5¡3.3 13.6¡2.2 13.5¡3.8 12.1¡4.4 11.7¡2.7 13.5¡3.3
Diagnosis
ErA/jSpA 11 10 24 0 0 0
Oligoarticular JIA 0 0 0 6 0 0
Polyarticular JIA 0 0 0 5 0 0
Analysis
DNA microarray 11 0 0 0 4 4
qRT-PCR 11 10 24 11 4 12
Medications
NSAID1 11 10 24 11 0 0
DMARD2 0 0 15 4 0 0
GC3 0 0 9 2 0 0
HLA genotype
B7 (OR52.61) 1 2 5 NA NA NA
B27 (OR55.69) 2 6 12 NA NA NA
B7/B27 (OR514.82) 8 0 1 NA NA NA
Odds ratio (OR) for disease development was calculated according to presence of HLA-B27 allele, HLA-B7 allele, or both, HLA-B27 and B7 alleles in a
cohort of 74 children from Croatia diagnosed with jSpA/ErA. [7]. It show us that odds for disease development are 2.61 times higher in children with HLA-B7
allele, 5.69 times higher in children with HLA-B27 allele and even 14.82 times higher in children with both HLA-B7 and HLA-B27 alleles than in children from
general population without this allele.
1Non-steroidal anti-inflammatory drugs.
2Disease-modifying antirheumatic drugs.
3Glucocorticoids.
doi:10.1371/journal.pone.0115416.t001
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this manner were annotated according to Nurtdinov et al., where each probe was
labeled according to its specificity and position in the genome [23]. Differentially
expressed genes were determined and ranked according to the magnitude of the
ratio of expression levels in patient and control samples, with the calculated p-
value designating a confidence measure. A correction of the calculated p-value for
multiple hypothesis testing was carried out with the Benjamini-Hochberg method
for probe intensities normalized with GCRMA algorithm [24]. Finally, a 2-tailed
Pearson correlation was performed to compare the expression ratios and p-values
of the probes calculated with both of the normalization procedures.
The analysis procedures presented here comply with MIAME guidelines
(Minimal Information About a Microarray Experiment) established by the
Microarray Gene Expression Data Society (http://www.mged.org). The data
discussed in this manuscript have been deposited in the NCBI’s Gene Expression
Omnibus (Edgar et al., 2002) and are accessible through the GEO Series accession
number GSE58667 ().
Bioinformatical analysis
A hierarchical clustering was performed using the dChip software on the pool of
all samples in order to determine gene clustering and to better visualize differences
in expression profiles between the jSpA patients and healthy control subjects.
Differentially expressed genes (p,0.05) were functionally annotated and classified
with the functional annotation tool of the database for annotation, visualization,
and integrated discovery (DAVID) [25], which provides integrated solutions for
the annotation and analysis of genome-scale datasets derived from high-
throughput technologies.
To determine whether a priori defined sets of genes show statistically significant
concordant differences between patients and healthy controls, a gene set
enrichment analysis (GSEA) using GSEA 1.0 software and .1325 pre-defined sets
of genes was performed [26]. The gene sets were defined based on prior biological
knowledge, e.g., published information about biochemical pathways or co-
expression in previous experiments.
Finally, to associate biological functions and diseases to genes differentially
expressed in jSpA/ErA patients the Ingenuity Pathway Analysis (IPA) v.7.6
software was used. The core technology behind this program is the Ingenuity
Knowledge Base, a repository of biological interactions and functional annota-
tions created from millions of individually modeled relationships between
proteins, genes, complexes, cells, tissues, drugs, and the disease. The IPA ‘‘Core
Analysis’’ was performed using the Ingenuity Knowledge Base (Genes only) as the
reference set, using direct and indirect relationships for network analysis, and data
from mammal species, and all tissues, cell lines and data sources.
Gene Expression in Juvenile Spondyloarthritis
PLOS ONE | DOI:10.1371/journal.pone.0115416 December 15, 2014 6 / 18
Gene selection for qRT-PCR analysis
Genes for qRT-PCR analysis were primarily selected according to the results of the
microarray expression study. Firstly, all genes with the expression ratio .1.5 or
,0.66 and p,0.05, as well as genes closely connected with them, were selected for
a manual database search (PUBMED/MEDLINE) in order to find studies relevant
for those genes. A ranked list of genes potentially important in the
pathophysiology of jSpA was then created based on the role of selected genes in
chronic inflammatory diseases as well as in various signaling pathways of interest.
Genes that were not previously connected with jSpA were ranked higher on the
list. Lastly, the results of the enriched functional related gene group’s analysis, the
gene set enrichment analysis, as well as the pathway and network analysis were
accounted for in the definitive gene selection.
qRT-PCR analysis
qRT-PCR analysis of the ten selected genes was performed for all the
participations (the 56 patients diagnosed with jSpA/ErA and other forms of JIA, as
well as the 12 healthy controls). The 2 mg of high-quality total RNA extracted
from whole blood was reversely transcribed using the SuperScript First-Strand
Synthesis system according to the manufacturer’s protocol (Invitrogen). The
expression of the selected genes was measured with the LightCycler FastStart DNA
Master SYBR Green kit (Roche Diagnostics, Mannheim, Germany) and
LightCycler instruments (Roche Diagnostics, Mannheim, Germany). The
sequences of primers used for the qRT-PCR are shown in Table 2. Relative gene
expressions were calculated by the 22DDCt method, in which Ct indicates cycle
threshold, the fractional cycle number where the fluorescent signal reaches
detection threshold. The average fold change was computed using the average
difference in DCt between the genes and internal control, for which b-actin was
used.
Results
Global gene expression changes
The Affymetrix platform and statistical analysis with the MAS5 normalization
algorithm identified 745 significantly changed genes (target intensity .100,
p,0.05, average expression ratio .1.5 or ,0.66) in 11 jSpA/ErA patients
compared with four healthy control subjects. Among these genes, 197 had lower
and 548 higher expression. The expression ratio and p-value of probes normalized
with MAS5 algorithm showed significant correlation at 0.01 level with the
expression ratio of probes normalized with GRCMA algorithm. The correlation
coefficient (r) was 0.432 for the expression ratios and 0,249 for the p-value.
Among the 745 filtered genes r was 0.854 for the expression ratios and 0.185 for
the p-value.
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Gene Ontology analysis using DAVID
The analysis of the enriched functional related gene groups with the DAVID
software indicated four gene groups with enrichment score (ES).1.5 from the list
of overexpressed genes and ten gene groups with enrichment score (ES).3 from
the list of underexpressed genes.
In the first group of gene ontology (GO) terms created from the list of
overexpressed genes, the majority of the enriched terms were associated to protein
kinase activation (CXCR4 gene selected for the qRT-PCR analysis was in this
group); in the second group the majority of terms were related to biological
processes associated with cell death (CXCR4, TLR4 and NLRP3 genes selected for
the qRT-PCR analysis were in this group); in the third group the enriched terms
were describing various cell components (DUSP6 gene selected for the qRT-PCR
analysis was in this group); finally, in the fourth group the majority of the
enriched terms were linked to vacuole, vacuolar membrane and endosome.
In the first group of the GO terms created from the list of the underexpressed
genes, the majority of the enriched terms were describing cell components such as
various lumens inside cell and cell organelles. The enriched terms in the second
group were describing the cell components associated with chromosomes and
chromatin. One of the genes in both of these groups was also the MYST3 gene
selected for the qRT-PCR analysis. In the third group, the majority of the enriched
terms were associated with transcription factors containing Zinc finger and PHD
finger motifs. The MYST3 gene was represented in this group as well. In the fourth
group the majority of the terms were associated with nucleotide binding
(MAP2K2 gene included in the qRT-PCR analysis was in this group). The fifth
group of GO terms was chiefly associated with chromatin organization,
modification and regulation while the sixth group of genes contained terms
related to the biological processes associated with the regulation and control of the
cell cycle. In the seventh group the terms were mostly associated with RNA
splicing and processing, in the eight group with cell cycle and cell division and in
the ninth group the terms were describing DNA damage response, metabolic
Table 2. Primer sequences used for the qRT-PCR.
Gene Forward Reverse
TLR4 ATGCTGCCGTTTTATCACGGA CTAAACTCTGGATGGGGTTTCC
NLRP3 GAGGCACAGACAGACCCAGT AACAGAGCTTGGTGGGTGAG
PTPRN2 GCTCCAAAACCAGATGCCTG GGTCCGAGAACCTCTCTGTCT
CXCR4 TGCCCACCATCTACTCCATCA AGGATGACCAATCCATTGCCC
TNFSF4 TGCTCTTCAGGTATCACATCGG ATGACTGAGTTGTTCTGCACC
DUSP6 AGCTCAATCTGTCGATGAACG GCGTCCTCTCGAAGTCCAG
MAP2K2 CCAAGGTCGGCGAACTCAAA TCTCAAGGTGGATCAGCTTCC
MAPKBP1 AAGGGTTTCTCGTCATAATGGC CGGTTTCCTGCCTTACTCCTG
MYST3 TCACCAGCAGTTACGATTGGC CATCCACGTTGGTTGCTTTAGT
PTPN12 CCCAGCGGGAGGTATTCACTATG GATCTCTTGGTCCTTTGGGTTTTC
b-ACTIN TCCCTGGAGAAGAGCTACGA AGGAAGGAAGGCTGGAAGAG
doi:10.1371/journal.pone.0115416.t002
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processes involving DNA and stress associated cell response. Finally, the terms
enriched in the tenth group were describing cell components associated with
cytoskeleton and organelles not bound to cell membrane. One of the genes in this
group was also the MYST3 gene.
GSEA analysis
The total number of gene sets represented in jSpA/ErA patients identified with
GSEA was 634 among which 23 gene sets had a nominal p-value ,0.05. The total
number of sets with NES.1 was 483. In healthy subjects, the total number of gene
sets identified with GSEA was 813, among which 87 gene sets had a nominal p-
value ,0.05 and 284 sets had NES.1. Only one gene set was significantly
enriched with FDR,0.25. Three gene sets were significant in patients with jSpA:
the HOX signal pathway, granule the cell survival pathway and the T cell
activation pathway. Many genes involved in the HOX signal pathway are also
associated with the development of the myelodysplastic syndrome and acute
myeloid leukemia, while many genes in the granule cell survival pathway are
associated with the MAPK signal pathway. One of the genes involved in the T cell
activation pathway set of genes is TNFSF4, which was used for further qRT-PCR
analysis.
IPA network and pathway analysis
Network and pathway analysis with the IPA software showed that the genes
differentially expressed in jSpA/ErA patients were involved in multiple functional
categories including cell death, gene expression, cellular growth and proliferation,
cancer, cellular development, homological system development and function,
hematopoiesis, genetic disorder, neurological diseases, DNA replication, recom-
bination and repair, connective tissue disorders and cell mediated immune
response. In the primary category of functions related to diseases and disorders,
functional categories mostly associated with the genes differentially expressed in
jSpA/ErA patients were hereditary disorders as well as inflammatory, infectious
and immunological diseases. One of the genes associated with inflammatory and
infectious functional categories is also the TLR4 gene, which was selected for
further qRT-PCR analysis. In the primary category of processes related to
molecular and cellular functions mostly associated functional categories were cell
death, gene expression, cell cycle and cellular development. Finally, in the primary
category of functions related to the development and functions of the
physiological system, functional categories mostly associated with genes
differentially expressed in jSpA/ErA patients were hematological system devel-
opment and function as well as hematopoiesis.
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qRT-PCR analysis
A qRT-PCR data confirmation was performed for six genes that had significantly
higher expression in jSpA patients (TLR4, NLRP3, PTPRN2, CXCR4, DUSP6,
TNFSF4), for three genes that had significantly lower expression (MAP2K2,
MAPKBP1, MYST3) and for one gene that had fold change and p-value very close
to the values selected as significant (PTPN12). This gene also has a potentially
important but still unclear role in immune diseases. The results of the DNA
microarray analysis for the selected genes are shown in Table 3. A qRT-PCR
analysis was performed in the same group of patients in which the DNA
microarray was performed (P1), in the new groups of treated and untreated jSpA/
ErA patients (P2 and P3) as well as in the group of patients diagnosed with oligo-
or polyarticular form of JIA (P4), as shown in Table 1. The expression of the
selected genes in those groups of patients was compared with the expression in the
group of healthy control subject (C2) and the results are shown in Table 4. More
specifically, a qRT-PCR analysis of the selected genes in the first group of patients
(P1) exhibited a significant (p,0.05) fold change for four genes. Two of them
(TLR4, CXCR4) had higher and two (MAPKBP1, PTPN12) had lower expression.
In the second group of patients (P2), the qRT-PCR analysis of the selected genes
showed significant (p,0.05) fold change for five genes, among which two had
higher (TLR4, CXCR4) and three had lower expression (NLRP3, PTPRN2,
PTPN12). In the third group of patients (P3), the qRT-PCR analysis showed
significant (p,0.05) fold change for five genes. Among these genes one had higher
(CXCR4) and four had lower expression (NLRP3, TNFSF4, MAPKBP1, PTPN12).
Finally, the qRT-PCR analysis of the selected genes showed no significant fold
change in the forth group of patients (P4).
Discussion
The present study differs from previous studies in a variety of methodological
ways such as the avoidance of pooling all JIA subtype patients together, the use of
whole blood (which avoids the potential artifact induced by isolating leukocytes
or leukocyte subsets), and a much larger number of the transcripts studied per
patient (54.675 probe sets). To our best knowledge this is the first study to
comprehensively evaluate whole blood gene expression patterns in undiffer-
entiated jSpA/ErA patients diagnosed with ILAR classification criteria for JIA. All
of the patients were younger than 16 years of age at the time of the disease onset
and they also fulfilled ESSG and Amor criteria for SpA. Patients with AS, PsA, ReA
and IBD were excluded while the aim of the present study was to show the activity
of the genes in undifferentiated patients which still can progress or regress to any
of the mentioned forms of SpA. This allowed us to compare the gene activity in
differentiated and undifferentiated patients; e.g. TLR4 and CXCR4 were
overexpressed in the present study, as well as in other gene expression studies
performed in patients diagnosed with AS and PsA [11, 16]. The full impact of this
could come after the gene expression profiling is repeated in the same cohort of
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patients over the course of time, which we plan to do. It is unfortunate that there
was no statistically significant difference in the expression of genes whose
polymorphisms are associated with the risk for development of AS [8]. One of the
possible explanations is that SNPs has to be in special loci inside the gene, the so-
called expression quantitative trait loci (eQTL), to influence gene expression [27].
Table 3. Results of DNA microarray analysis for genes selected for further qRT-PCR analysis.
Symbol Name of the gene Probeset annotation Intensity measurements Fold change p
TLR4 Toll-like receptor 4 232068_s_at 248.25 +2.13 0.02
NLRP3 NLR family, pyrin domain containing 3 207075_at 130.39 +1.97 ,0.01
PTPRN2 Protein tyrosine phosphatase,
receptor type, N polypeptide 2
203029_s_at 189.93 +1.78 0.01
CXCR4 Chemokine (C-X-X motif) receptor 4 217028_at 4753.75 +1.60 0.02
DUSP6 Dual specificity phosphatase 6 208892_s_at 1724.53 +1.71 0.05
TNFSF4 Tumor necrosis factor (ligand)
superfamily, member 4
207426_s_at 137.50 +1.95 ,0.01
MAP2K2 Mitogen-activated protein kinase
kinase 2
213490_s_at 193.45 21.55 0.03
MAPKBP1 Mitogen-activated protein kinase
binding protein 1
213394_at 130.88 22.17 0.01
MYST3 MYST histone acetyltransferase
(monocytic leukemia) 3
216361_s_at 101.78 23.26 ,0.01
PTPN12 Protein tyrosine phosphatase,
non-receptor type 12
202006_at 710.88 +1.57 0.07
216884_at 6.09 21.05 0.91
216915_s_at 26.69 +2.30 0.11
Every gene on the GeneChip is represented with one or more probe set. The intensity of every probe set can be measured and the ratio of probe set
intensities on experiment and baseline arrays is used for fold change calculation. In order to show significant differences in probe set intensities, the p-value
is calculated. Presented fold change and p-value were calculated after probe set intensities normalization with MAS5 algorithm.
doi:10.1371/journal.pone.0115416.t003
Table 4. Results of qRT-PCR analysis for selected genes in all group of patients.
Gene P1 P2 P3 P4
FC p FC P FC P FC p
TLR4 +4,36 0,05 +3,91 ,0,01 +1,32 0,26 +1,37 0,30
NLRP3 +2,06 0,53 25,00 ,0,01 23,70 0,05 22,13 0,21
PTPRN2 +2,60 0,54 25,55 0,01 +1,41 0,59 22,78 0,17
CXCR4 +1,89 ,0,01 +1,87 ,0,01 +1,37 0,03 +1,23 0,43
DUSP6 21,12 0,72 21,19 0,52 +1,11 0,66 21,06 0,71
TNFSF4 +1,02 0,97 21,16 0,46 21,56 0,04 +1,26 0,23
MAP2K2 21,25 0,44 1,04 0,80 21,07 0,75 +1,01 0,96
MAPKBP1 23,12 0,02 21,39 0,29 21,96 0,05 21,05 0,75
MYST3 21,10 0,73 21,05 0,79 +1,03 0,86 21,56 0,34
PTPN12 23,70 ,0,01 22,63 ,0,01 22,44 ,0,01 21,06 0,84
Fold change (FC) represents the relative increase (+) or decrease (2) of expression calculated using the 2DDCt method, and p stands for the calculated p-
value.
doi:10.1371/journal.pone.0115416.t004
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Further on, gene expression may not be the only mediator for the relation between
SNPs and the disease, while other biomarkers, such as DNA methylation, proteins,
metabolites of the gene product in the blood, immunological or biochemical
markers in the serum, and environmental factors can also serve as potential
mediators, depending on the context or the disease to be studied [28].
Spondyloarthritis and HLA genes
The dominance of a single gene in a complex genetic disease places HLA-B27 and
spondyloarthritis in an unusual place among immune-mediated and autoimmune
inflammatory disorders [3]. Previous studies have shown that ERAP and HLA-
B27, but not HLA-B7, jointly contribute to predisposition for AS in animal
model, and that HLA-B7 is associated with undifferentiated SpA in the HLA-B27
negative group of patients [29, 30]. The majority of jSpA patients participating in
our study had the HLA-B27 and/or HLA-B7 alleles with significant OR for disease
development, which was the highest when the both antigens were present (see
introduction). However, as already explained, the HLA genes are only a few of the
many genes involved in the disease pathogenesis and our study pointed to other
important contributors, many of which were never before put in the context of
jSpA/ErA.
Bioinformatical analysis
To elucidate genes involved in this complex disease we preformed a whole
transcriptome analysis. Due to the vast amount of data gathered in such a manner
it is very important to select an appropriate analysis that could lead us to valuable
conclusions. Thus we performed several different bioinformatical analyses that
gave some biological meaning to the results of the microarray experiment. The
analysis of the enriched functional related gene groups showed that the blood cells
of patients with jSpA/ErA, from which RNA was isolated, have higher activity of
various processes connected with apoptosis and lower activity of processes
connected with transcription and cell cycle, which could indicate dysfunction of
this cells on many levels. It is important to point out that six genes (CXCR4,
TLR4, NLRP3, DUSP6, MYST3, MAP2K2) were selected for further validation
based on the results of this analysis. GSEA showed that many genes differentially
expressed in the blood cells of study patients are connected to processes believed
to be important in pathogenesis of SpA, such as gene expression, morphogenesis,
cell differentiation, Wnt and MAPK signal pathway and T cell activation. Based on
the results of a GSEA analysis we selected the TNFSF4 gene for further validation.
Finally, the results of network and pathway analysis lead us to conclusion that
mechanisms similar to those observed in inflammatory, genetic, immunological
and infectious diseases also have important role in development of jSpA/ErA. The
results of this analysis once more underlined the importance of TLR4 gene.
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Statistical analysis
When evaluating microarray expression data, we must ask whether the results are
accurate for the particular biological system under study and do the data
fundamentally describe the phenomenon being investigated [31]. Since there is
still no consensus about the most appropriate normalization procedure for
microarray experiments, we used the two most common algorithms.
Unfortunately, correlation coefficients of expression ratios and especially of p-
values calculated after normalization procedures with both algorithms were not
especially high.
qRT-PCR analysis
To independently confirm data gathered in the microarray experiments, ten genes
were carefully selected for a qRT-PCR analysis in the same group of patients in
which microarray was preformed. Further on, for confirmation of data
universality the same genes were analyzed in new groups of untreated and treated
patients diagnosed with jSpA/ErA. Finally, to confirm that the retrieved data were
specific for patients with jSpA/ErA, the qRT-PCR analysis of the selected genes
was performed in a group of patients diagnosed with other forms of JIA.
Role of the genes selected for further analysis
TLR-4 mediates NF- kB activation, cytokine secretion and the inflammatory
response [32]. Serum TLR-4 protein and mRNA levels, as well as TLR-4 gene
expression were previously found to be significantly higher in adult AS patients
[16, 33]. In our study, this gene was overexpressed only in cohort of untreated (P1
and P2), but not in treated (P3) patients, which could mean that the standard
therapy or the course of the disease influence the expression of this gene.
Product of CXCR4 is a chemokine receptor with a previously described role in
the pathophysiology of SpA [34]. CXCR4 and its ligand CXCL12 have been
suggested to be important in retaining inflammatory cells within the joint, and
recently have been incorporated into the pathogenesis of IBD [35, 36]. Since it was
overexpressed in all of our jSpA/ErA patients (P1–P3) we believe it might
contribute to the mucosal disregulation, leading to ‘‘low-grade IBD’’. This is in
accordance with the hypothesis that the gut is the primary site of pathology and
that the recirculation of the activated immune cells from the gut to
musculoskeletal sites leads to entheseal complex and joint inflammation [37–39].
The reduced expression of NLRP3 gene is a novel observation in jSpA/ErA and
is especially intriguing. Polymorphisms in other NLR and related genes have been
implicated in diseases that share clinical features with SpA, including Behc¸et’s
disease, Crohn’s disease and psoriatic arthritis, while reduced NLRP2 expression
was found in adults with axial spondyloarthritis [13]. Recent studies suggest that a
defective NLRP3 inflammasome signaling in the gut contributes to IBD through
increased permeability across the epithelial barrier and the induction of
detrimental immune responses against invading commensals [40]. Therefore, the
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downregulated NLRP3 gene in jSpA/ErA patients might reflect development of a
subclinical inflammation of the gut mucosa (‘‘low-grade IBD’’), leading to a leaky
gut.
Three different PTPs were selected for further qRT-PCR analysis in our study
(PTPRN2, DUSP6, PTPN12), and we found lower expression of PTPN12 in all
cohorts of jSpA/ErA patients. According to previous studies, PTPN12 is a negative
regulator of inflammation and intestinal cell migration, as well as a positive
regulator of osteoclast activity, all of which are processes important for the
patophisiology of jSpA/ErA [41–44]. A recent oncological study showed that the
PTPN12 gene could be silenced by methylation, giving a possible explanation for
the PTPN12 downregulation [42].
Other genes selected for the qRT-PCR analysis could potentially also have
important role in the jSpA development. MAP2K2 and MAPKBP1, along with
majority of the other selected genes, are involved in NFkB and MAPK signaling
pathways, known to be important for the regulation of the immune response [45].
TNFSF4 is one of the costimulatory molecules important for the lymphocyte
activation, while MYST3 is involved in epigenetic regulation [46, 47].
It is important to stress that none of the genes showed a statistically significant
expression difference in other JIA patients (P4), possibly meaning that the
observed expression profiles are specific for jSpA/ErA patients.
Important limitations
The weakness of microarrays is its susceptibility to great experimental variability
and the lack of a single unanimously accepted optimal method of statistical
analysis. An important consideration in the interpretation of gene expression
profiles obtained from complex mixtures of cells is the influence of cellular
composition. Genes that are referred to as ‘up- or down-regulated’ may actually
be ‘over- or under-represented’ due to differences in abundance of cell
populations [20]. High-throughput technologies are by their nature hypothesis
generating and the hypotheses presented in this study must be validated in other
cohorts while the biological relevance of gene expression differences identified
here remain to be determined at protein and organism levels. Nevertheless, the
results of the microarray analysis in the present study were validated by qRT-PCR,
which is referred to as a golden standard method for gene expression
measurement [48]. Validation was performed in the new cohort of treated and
untreated patients diagnosed with jSpA, as well as in the cohort of patients
diagnosed with other forms of JIA. This independent confirmation of results, as
well as confirmation of data universality and specificity for jSpA patients, gave
more significance to microarray analysis results [31]. Unfortunately, the
microarray expression was not confirmed by the qRT-PCR in jSpA/ErA patients
group for MYST3, DUSP6 and MAP2K2, while it was not consistent for NLRP3,
PTPRN2, TNFSF4 and MAPKBP1. Interestingly, the PTPN12 gene showed a
statistically significant expression in all groups of jSpA/ErA patients when analysis
was preformed with qRT-PCR, but not with microarray. We believe this is
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possibly due to a small number of patients, which is another important limitation
of the study. Finally, a major limitation of our study is a lack of evidence of
importance for the identified markers with in vitro assays or in vivo animal
studies.
Conclusions
The present study has identified differences in the expression of genes related to
various processes responsible for jSpA/ErA development. Among these, the genes
of highest importance were TLR-4 and NLRP3, which can lead to the
development of systemic autoimmunity, as well as CXCR4 and PTPN12, which
can drive other processes important for the pathophysiology of jSpA/ErA. Several
differentially expressed genes (e.g. TLR-4, CXCR4) replicate findings in other
studies providing further confidence in ours [11, 16, 49]. We strongly believe that
our results represent an important step toward a better understanding of the
molecular mechanisms and complex pathophysiology of jSpA/ErA. The high-
lighted genes and their products could have a prognostic value and potential
therapeutic use, although further research at the level of epigenome and proteome
in a larger cohort of patients are needed to make this feasible.
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